Prognostic impact of genetic mutations in unfavorable cancer of unknown primary site

被引：0

作者：

Tang, Chengyu ^{[1
,2
]}

Lu, Hsueh-Ju ^{[3
,4
]}

Liu, Hsuan ^{[5
,6
,7
,8
]}

Huang, Chi-Ying ^{[9
]}

Chang, Peter Mu-Hsin ^{[1
,2
,9
]}

机构：

[1] Taipei Vet Gen Hosp, Div Med Oncol, Dept Oncol, Taipei, Taiwan

[2] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan

[3] Chung Shan Med Univ Hosp, Div Med Oncol, Dept Internal Med, Taichung, Taiwan

[4] Chung Shan Med Univ, Sch Med, Taichung, Taiwan

[5] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan

[6] Chang Gung Mem Hosp, Div Colon & Rectal Surg, Lin Kou Med Ctr, Taoyuan, Taiwan

[7] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan

[8] Chang Gung Univ, Dept Cell & Mol Biol, Coll Med, Taoyuan, Taiwan

[9] Natl Yang Ming Chiao Tung Univ, Inst Biopharmaceut Sci, Taipei, Taiwan

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.247

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MO36-4

引用

页码：S1419 / S1419

页数：1

共 50 条

[41] Radiotherapeutic concepts in cancer of unknown primary site [J].

Krug, D. ;

Debus, J. ;

Sterzing, F. .

RADIOLOGE, 2014, 54 (02) :145-150

[42] AKT as Locus of Cancer Unknown Primary Site [J].

Radisavljevic, Ziv .

JOURNAL OF CELLULAR BIOCHEMISTRY, 2016, 117 (05) :1066-1068

[43] Inflammation as a validated prognostic determinant in carcinoma of unknown primary site [J].

Z Mohamed ;

D J Pinato ;

F A Mauri ;

K-W Chen ;

P M-H Chang ;

R Sharma .

British Journal of Cancer, 2014, 110 :208-213

[44] New Prognostic Index to Predict Survival in Patients with Cancer of Unknown Primary Site with Unfavourable Prognosis [J].

Trivanovic, D. ;

Petkovic, M. ;

Stimac, D. .

CLINICAL ONCOLOGY, 2009, 21 (01) :43-48

[45] Cancer of unknown primary site: Missing primary or missing biology? [J].

Pentheroudakis, George ;

Briasoulis, Evangelos ;

Pavlidis, Nicholas .

ONCOLOGIST, 2007, 12 (04) :418-425

[46] Exceptional response to immunotherapy monotherapy in a patient with an unfavorable subset of cancer of unknown primary [J].

Huang, Xiangzhong ;

Ren, Dongqing ;

Sun, Qiulian ;

Xu, Xinjian ;

Ding, Yiwen .

QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2023, 13 (12) :8832-8838

[47] Prognostic impact of primary tumor site location in metastatic colorectal cancer (mCRC). [J].

Matos, Ignacio ;

Ortiz, Carolina ;

Elez, Elena ;

Argiles, Guillem ;

Grasselli, Julieta ;

Macarulla, Teresa ;

Capdevila, Jaume ;

Alsina, Maria ;

Sauri, Tamara ;

Hierro, Cinta ;

Verdaguer, Helena ;

Sanz-Garcia, Enrique ;

Maria Martinez, Ana ;

Espin, Eloy ;

Dopazo, Cristina ;

Landolfi, Stefania ;

Nuciforo, Paolo ;

Vivancos, Ana ;

Dienstmann, Rodrigo ;

Tabernero, Josep .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)

[48] Cancer of unknown primary site with pathological characteristic of the breast cancer [J].

Goto, Keiko ;

Hashimoto, Jun ;

Tanabe, Yuko ;

Kodaira, Makoto ;

Yamamaoto, Harukaze ;

Yunokawa, Mayu ;

Yonemori, Kan ;

Shimizu, Chikako ;

Tamura, Kenji ;

Fujiwara, Yasuhiro .

ANNALS OF ONCOLOGY, 2015, 26 :111-112

[49] Immunological evaluation of personalized peptide vaccination for patients with histologically unfavorable carcinoma of unknown primary site [J].

Shinjiro Sakamoto ;

Shigeru Yutani ;

Shigeki Shichijo ;

Michi Morita ;

Akira Yamada ;

Kyogo Itoh ;

Masanori Noguchi .

Cancer Immunology, Immunotherapy, 2016, 65 :1223-1231

[50] Immunological evaluation of personalized peptide vaccination for patients with histologically unfavorable carcinoma of unknown primary site [J].

Sakamoto, Shinjiro ;

Yutani, Shigeru ;

Shichijo, Shigeki ;

Morita, Michi ;

Yamada, Akira ;

Itoh, Kyogo ;

Noguchi, Masanori .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (10) :1223-1231

← 1 2 3 4 5 →